• Rongrong Ge, Shuying Chen, Jiawang Jiang, Bangmin Wang, You Zeng, Qianan Cao, Jun Wu, and Yunfeng Liu.
• Jiangxi University of Traditional Chinese Medicine, Nanchang, China.
• Medicine (Baltimore). 2021 Dec 3; 100 (48): e27810.

BackgroundPlantar fasciitis (PF) is the most common cause of heel pain in adult. There are a variety of ways to treat PF, but these treatments have varied result in their effectiveness, and exist different degrees of limitations. At present, clinical studies focus on the effect of glucocorticoid (GC) and platelet rich plasma (PRP) in the treatment of PF, but there is a lack of systematic evaluation PRP and GC's clinical effect towards PF. This study aims to evaluate the long-term efficacy of GCs and PRP in the treatment of PF by means of meta-analysis.MethodsThe literature of a randomized controlled clinical trial of PRP in the treatment of plantantifasciitis was searched on the Internet. Retrieve 7 databases. EndNote X9 software was used for document management. The Jadad scale was used to score the literature. Risk assessment of the literature was conducted according to Cochrane's systematic evaluation manual 5.0. RevMan5.3 software was used for literature risk bias analysis. Stata12.0 software is used for sensitivity analysis.ResultsThis study will provide effective evidence-based evidence for the long-term efficacy of PRP and GC in treating PF.ConclusionA systematic review and meta-analysis were conducted for the comparison of the long-term effect of PRP and GC on plantar fascia in the treatment of PF.Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

25 keywords...

hide…